TABLE 4.
Adjusted reporting odds ratios of peripheral neuropathy events in cases with proteasome inhibitors and factor Xa inhibitors.
| Variable | Multivariate analysis | ||
|---|---|---|---|
| Adjusted ROR (95%CI) | p value | ||
| Patient gender | 0.022 | ||
| Male | reference | ||
| Female | 0.915 (0.848–0.987) | 0.022 | |
| Patient age group (years) | <0.001 | ||
| 18–34 | reference | ||
| 35–64 | 1.901 (1.065–3.393) | 0.030 | |
| 65–74 | 1.936 (1.084–3.455) | 0.025 | |
| >75 | 1.471 (0.823–2.631) | 0.193 | |
| Reporting year | 0.953 (0.946–0.961) | <0.001 | |
| PI | 4.490 (4.136–4.874) | <0.001 | |
| FXaI | 0.194 (0.168–0.225) | <0.001 | |
| PI&FXaI | 7.890 (5.321–11.698) | <0.001 | |
CI, confidence interval; FXaI, factor xa inhibitors; PI, proteasome inhibitors; ROR, reporting odds ratios.